Addition of pioglitazone or bedtime insulin to maximal doses of sulfonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference31 articles.
1. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998
2. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus;Ohkubo;Diabetes Res Clin Pract,1995
3. Standards of medical care for patients with diabetes mellitus;Diabetes Care,2002
4. Glycemic control with diet, sulphonylurea, metformin or insulin in patients with type 2 diabetes. Progressive requirement for multiple therapies (UKPDS 49);Turner;JAMA,1999
5. Health care and health status and outcomes for patients with type 2 diabetes;Harris;Diabetes Care,2000
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Effects of Basal Insulin on Lipid Profile Compared to Other Classes of Antihyperglycemic Agents in Type 2 Diabetic Patients;The Journal of Clinical Endocrinology & Metabolism;2020-04-09
2. Pioglitazone for the Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis;The Journal of Clinical Endocrinology & Metabolism;2019-12-10
3. Fiches cliniques;Diabetologie;2019
4. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease;Cochrane Database of Systematic Reviews;2018-09-24
5. Antidiabetic Drugs and the Kidney;Current Pharmaceutical Design;2018-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3